Continued strength in ortho robotics placements and a crowd of new product launches in Q123 set the stage for growth in the remainder of the year.
The Q123 US Ortho Enabling Tech Market declined slightly by -0.6% YoY according to SmartTRAK Financial Dashboard. Stryker* (SYK) remained the market leader with 55.6% share, followed by Smith+Nephew* (
SNN), Zimmer Biomet* (ZBH) and DePuy Synthes* (JNJ). For detailed Q132 revenues and shares by company in the US, EU and ROW, see SmartTRAK Ortho Enabling Tech Financial Dashboard.
Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Ortho Enabling Tech Market Recap* are:
- Complete Q123 Otho Enabling Tech Market Overview
- SmartTRAK's Expert Market Analysis and Insights
- All US Ortho Enabling Tech Companies' News, Revenues, Data, Charts and Market Shares
- Robust Q123 Robotics Performances by Company
- Stryker
- Zimmer Biomet
- Smith+Nephew
- JNJ/Depuy Synthes
- New Product Introductions
- Robotics and Ecosystem Launches
- Navigation and Planning Innovations
- SmartTRAK's Selected Highlights from Q123 Conferences
- JP Morgan 41st Annual Healthcare Conference
- Canaccord Genuity 2023 Musculoskeletal Conference
- AAOS 2023 Annual Meeting
In an International Society for Technology in Arthroplasty (ISTA) presentation at the American Academy of Orthopaedic Surgeons 2023 (AAOS 2023) Annual Meeting, President, Digital, Robotics and Enabling Technology at SYK Robert Cohen discussed innovations including a fully connected operating room for a common user experience with planning and mixed-reality guidance combined with robotics and data transfer capabilities. Enabling technology continues to see adoption and integration in orthopedics and with it, the introduction of ...
Read the entire Q123 Ortho Enabling Tech Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*
*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.